{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:18:19Z","timestamp":1787170699711,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2022SF-029"],"award-info":[{"award-number":["2022SF-029"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570180"],"award-info":[{"award-number":["81570180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472402"],"award-info":[{"award-number":["81472402"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103522"],"award-info":[{"award-number":["82103522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021TQ0362"],"award-info":[{"award-number":["2021TQ0362"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.canlet.2022.215812","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:01:34Z","timestamp":1656590494000},"page":"215812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Phosphorylation of PBK\/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth"],"prefix":"10.1016","volume":"544","author":[{"given":"Kaijing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingge","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linni","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215812_bib1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215812_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","article-title":"Burkitt's lymphoma: clinicopathologic features and differential diagnosis","volume":"11","author":"Ferry","year":"2006","journal-title":"Oncol."},{"key":"10.1016\/j.canlet.2022.215812_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hon.914","article-title":"Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach","volume":"27","author":"Bellan","year":"2009","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.canlet.2022.215812_bib4","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1182\/blood-2012-12-475558","article-title":"Trends in survival of patients with Burkitt lymphoma\/leukemia in the USA: an analysis of 3691 cases","volume":"121","author":"Costa","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215812_bib5","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/annonc\/mdt414","article-title":"A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M\/IVAC regimen for untreated Burkitt's lymphoma","volume":"24","author":"Evens","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2022.215812_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/S0140-6736(15)01317-3","article-title":"Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Ribrag","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215812_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cam4.1870","article-title":"Trends in survival of patients with stage I\/II Burkitt lymphoma in the United States: a SEER database analysis","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2022.215812_bib8","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S2152-2650(20)30455-9","article-title":"Burkitt lymphoma - subtypes, pathogenesis, and treatment strategies","volume":"20","author":"Noy","year":"2020","journal-title":"Clin. Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.canlet.2022.215812_bib9","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1073\/pnas.090102397","article-title":"Characterization of PDZ-binding kinase, a mitotic kinase","volume":"97","author":"Gaudet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2022.215812_bib10","doi-asserted-by":"crossref","first-page":"21525","DOI":"10.1074\/jbc.M909629199","article-title":"Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells","volume":"275","author":"Abe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215812_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1440-169X.2005.00834.x","article-title":"Expression and phosphorylation of TOPK during spermatogenesis","volume":"47","author":"Fujibuchi","year":"2005","journal-title":"Dev. Growth Differ."},{"key":"10.1016\/j.canlet.2022.215812_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbrc.2004.10.133","article-title":"Characterization of a MAPKK-like protein kinase TOPK","volume":"325","author":"Matsumoto","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2022.215812_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jmb.2007.04.067","article-title":"A mitotic kinase TOPK enhances Cdk1\/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis","volume":"370","author":"Abe","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.canlet.2022.215812_bib14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/bcmd.2001.0452","article-title":"PBK\/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells","volume":"27","author":"Simons-Evelyn","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.canlet.2022.215812_bib15","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41419-018-1131-7","article-title":"T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics","volume":"9","author":"Herbert","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2022.215812_bib16","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.18632\/oncotarget.6826","article-title":"TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41419-019-2020-4","article-title":"Targeting the COX2\/MET\/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells","volume":"10","author":"Xiao","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2022.215812_bib18","first-page":"1785","article-title":"TOPK is regulated by PP2A and BCR\/ABL in leukemia and enhances cell proliferation","volume":"54","author":"Uchida","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2022.215812_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2007.04.048","article-title":"Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells","volume":"133","author":"Zhu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2022.215812_bib20","doi-asserted-by":"crossref","first-page":"24483","DOI":"10.18632\/oncotarget.8231","article-title":"Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon","volume":"7","author":"Xiao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib21","doi-asserted-by":"crossref","first-page":"29138","DOI":"10.1074\/jbc.M110.135905","article-title":"T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity","volume":"285","author":"Zykova","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215812_bib22","doi-asserted-by":"crossref","first-page":"29601","DOI":"10.1074\/jbc.M111.225813","article-title":"T-LAK cell-originated protein kinase (TOPK) phosphorylation of MKP1 protein prevents solar ultraviolet light-induced inflammation through inhibition of the p38 protein signaling pathway","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215812_bib23","doi-asserted-by":"crossref","first-page":"22460","DOI":"10.18632\/oncotarget.7984","article-title":"Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010277","article-title":"TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis","volume":"6","author":"Matsuo","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2022.215812_bib25","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/MCB.24.10.4557-4570.2004","article-title":"Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta","volume":"24","author":"Kurzer","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215812_bib26","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.18632\/oncotarget.15114","article-title":"microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2\/STAT3 and MAP3K8\/ERK signaling pathways","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-018-3281-4","article-title":"P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6\/JAK2\/STAT3 signaling","volume":"446","author":"Wang","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2022.215812_bib28","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood-2018-03-841015","article-title":"B-cell receptor-mediated NFATc1 activation induces IL-10\/STAT3\/PD-L1 signaling in diffuse large B-cell lymphoma","volume":"132","author":"Li","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215812_bib29","doi-asserted-by":"crossref","first-page":"111495","DOI":"10.18632\/oncotarget.22847","article-title":"A novel orally available Syk\/Src\/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib30","doi-asserted-by":"crossref","first-page":"16686","DOI":"10.1074\/jbc.M116.736868","article-title":"Synthetic lethal screen demonstrates that a JAK2 inhibitor suppresses a BCL6-dependent IL10RA\/JAK2\/STAT3 pathway in high grade B-cell lymphoma","volume":"291","author":"Beck","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2022.215812_bib31","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2020.274506","article-title":"Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell Lymphoma","author":"Bastidas Torres","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2022.215812_bib32","first-page":"6255","article-title":"Inhibition of JAK2\/STAT3 signaling pathway suppresses proliferation of Burkitt's lymphoma Raji cells via cell cycle progression, apoptosis, and oxidative stress by modulating HSP70","volume":"24","author":"Xu","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.canlet.2022.215812_bib33","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2012-04-424630","article-title":"Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215812_bib34","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.4049\/jimmunol.158.9.4097","article-title":"Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase","volume":"158","author":"Giordano","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2022.215812_bib35","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1159\/000465455","article-title":"IL-6 enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro","volume":"41","author":"Wu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2022.215812_bib36","first-page":"1182","article-title":"[Intrathecal injection of AG-490 reduces bone-cancer-induced spinal cord astrocyte reaction and thermal hyperalgesia in a mouse model]","volume":"43","author":"Zhang","year":"2018","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.canlet.2022.215812_bib37","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1158\/0008-5472.CAN-06-1601","article-title":"PDZ-binding kinase\/T-LAK cell-originated protein kinase, a putative cancer\/testis antigen with an oncogenic activity in breast cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215812_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)00118-5","article-title":"Signaling to chromatin through histone modifications","volume":"103","author":"Cheung","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215812_bib39","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1158\/0008-5472.CAN-05-0197","article-title":"Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation","volume":"65","author":"Choi","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215812_bib40","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.23077","article-title":"Targeting the T-Lak cell originated protein kinase by OTS964 shrinks the size of power-law coded heterogeneous glioma stem cell populations","volume":"9","author":"Sugimori","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib41","first-page":"735","article-title":"[Burkitt's lymphoma]","volume":"24","author":"Afanas","year":"2011","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.canlet.2022.215812_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00277-017-3167-7","article-title":"Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens","volume":"97","author":"Oosten","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.canlet.2022.215812_bib43","first-page":"972","article-title":"Status and prognostic nomogram of patients with Burkitt lymphoma","volume":"19","author":"Lu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2022.215812_bib44","doi-asserted-by":"crossref","first-page":"12392","DOI":"10.18632\/oncotarget.3630","article-title":"TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer","volume":"6","author":"Sun","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib45","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.7314\/APJCP.2012.13.5.2145","article-title":"PBK\/TOPK expression during TPA-induced HL-60 leukemic cell differentiation","volume":"13","author":"Liu","year":"2012","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.canlet.2022.215812_bib46","doi-asserted-by":"crossref","first-page":"18763","DOI":"10.18632\/oncotarget.7708","article-title":"PDZ-binding kinase\/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth","volume":"7","author":"Vishchuk","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215812_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.59566\/IJBS.2006.2395","article-title":"Gossypol-induced differentiation in human leukemia HL-60 cells","volume":"2","author":"Wang","year":"2006","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2022.215812_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2020.07.015","article-title":"Activation of NF-kappaB by TOPK upregulates Snail\/Slug expression in TGF-beta1 signaling to induce epithelial-mesenchymal transition and invasion of breast cancer cells","volume":"530","author":"Lee","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2022.215812_bib49","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/1535-7163.MCT-17-0628","article-title":"Targeting PRPK function Blocks colon cancer metastasis","volume":"17","author":"Zykova","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2022.215812_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1349-7006.2009.01400.x","article-title":"Critical roles of T-LAK cell-originated protein kinase in cytokinesis","volume":"101","author":"Park","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2022.215812_bib51","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.cellsig.2013.08.013","article-title":"TOPK and PTEN participate in CHFR mediated mitotic checkpoint","volume":"25","author":"Shinde","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2022.215812_bib52","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/1060028019839650","article-title":"Baricitinib: the second FDA-approved JAK inhibitor for the treatment of rheumatoid arthritis","volume":"53","author":"Mogul","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.canlet.2022.215812_bib53","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-11-3851","article-title":"Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth","volume":"72","author":"Kim","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215812_bib54","article-title":"Targeting TOPK Sensitises Tumour Cells to Radiation-Induced Damage by Enhancing Replication Stress","author":"Herbert","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canlet.2022.215812_bib55","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1535-7163.MCT-17-0212","article-title":"ADA-07 suppresses solar ultraviolet-induced skin carcinogenesis by directly inhibiting TOPK","volume":"16","author":"Gao","year":"2017","journal-title":"Mol. Cancer Therapeut."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522002968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522002968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:17:15Z","timestamp":1778512635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522002968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":55,"alternative-id":["S0304383522002968"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215812","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphorylation of PBK\/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"215812"}}